Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Study on PET Imaging of Solid Tumors Using an MDM2/MDMX-Specific Probe

NCT06443762 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT06443762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06443762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Study on PET Imaging of Solid Tumors Using an MDM2/MDMX-Specific Probe
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Phase 1
Overall status
Completed
Start date
January 3, 2025
Completion date
May 23, 2025
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mdm2/mdmx gene mutation, nuclear medicine, positron emission tomography imaing